Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of SB4 in Healthy Male Subjects

NCT01865552 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
138
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Samsung Bioepis Co., Ltd.